Category - New Drugs
FDA Approves Jornay PM (methylphenidate) Extended-Release Capsules for Attention Deficit Hyperactivity Disorder (ADHD)
FDA Approves Arakoda (tafenoquine) for the Prevention of Malaria
FDA Approves Poteligeo (mogamulizumab-kpkc) for Mycosis Fungoides and Sézary Syndrome
FDA Approves Expanded Indication for Orkambi (lumacaftor/ivacaftor) in Children Ages 2-5 Years
Teva Announces Updated Indication and Vial Presentation for Granix (tbo-filgrastim) Injection in United States
FDA Approves Mulpleta (lusutrombopag) for Thrombocytopenia in Adults with Chronic Liver Disease
United Therapeutics Announces FDA Approval of the Implantable System for Remodulin
FDA Approves Azedra (iobenguane I 131) for Rare Adrenal Tumors